◆ 会议时间：2025年10月9-11日
◆ 会议地点：希腊 雅典

◆ 会议简介：

2025年第38届国际性病控制联盟(IUSTI)欧洲大会将于2025年10月9-11日在希腊雅典举行。
国际性病控制联盟(IUSTI)成立于1923年，是历史最悠久的致力于性传播感染（包括HIV/AIDS）预防与控制的非营利性国际组织，同时也是在世界卫生组织具有咨商地位的官方非政府组织。IUSTI关注性传播感染及其控制医学、科学和流行病学等方面。未经许可禁止复制转载镜像本站任何内容—领域国际医学会议网(lingyuint.com)。

38th Congress of the International Union against Sexually Transmitted Infections (IUSTI)-Europe

Date: October 9-11, 2025
Venue: Divani Caravel Hotel, Athens, Greece,

摘要征文投稿：

October 31, 2024
Registration & Call for abstracts opening

June 15, 2025
Deadline for abstract submission

June 30, 2025
Notification of abstract acceptance

July 15, 2025
Deadline for early bird registration

August 20, 2025
Congress program available

点此提交摘要>>>Submit Abstract>>>

• Available soon

Before accessing the submission form, please make sure that you have prepared your abstract according to the following guidelines:

All abstracts, regardless of whether they are submitted for oral, or poster presentations will be reviewed to appraise the quality of the work presented. The Scientific Committee will evaluate all abstracts submitted for presentation. The authors will be notified regarding acceptance of their abstracts and the type of presentation by June 30th, 2025.

Language: All abstracts should be submitted and presented in English, which is the official language of the Congress, using accurate grammar and spelling suitable for publication. If in doubt, please arrange for the review of your abstract by a native English speaker or by a university scientific publications office (or other similar facility) before submission, as it will be reproduced exactly as submitted. No proofreading will be done.

Corresponding Author: The abstract submission form should be completed by the Corresponding Author, who will be responsible for all future communications regarding the submitted abstract.

Account: Each submitter (Corresponding Author) is required to create a user account indicating an account email address and a password. The email and password indicated will be used for all online forms of the Congress (i.e. Registration Form).

Abstract Title:

• The abstract title should be brief and reflect the content of the abstract.
• The abstract title should be typed in lowercase letters, except for abbreviations and study names. Please be careful that your title might be truncated if you copy and paste it into the field.
• Do not refer to study results or conclusions in the title of the abstract. The title should objectively describe the study.

• Names of authors should be written in upper/ lower cases in the following way: {Full name with the first letter in upper case (e.g. John)} {Surname (Family Name) with the first letter in upper case (e.g. Smith)}
• Please enter the first name in full, followed by the surname (Family Name), for each author, without abbreviations (e.g. John Smith, and NOT J. Smith). The names, e-mail addresses and full affiliations of all authors should be entered.
• Each abstract can have a maximum of 25 authors.

• The text (excluding title, authors, and affiliations) should not exceed 350 words.
• Organize the abstract according to four sections, identified by the following headers:
• Background
• Material and Methods
• Results
• Conclusion
• Do not include illustrations with the abstract.
• Place abbreviations in parentheses immediately after the first mention of a term or phrase; the abbreviation can then be used throughout the abstract.
• Table(s), Figures, and photographs may be included.
• Describe the objectives and results of the research in the abstract so that the Abstract Evaluation Committee can evaluate the quality, originality, and completeness of the abstract. Abstracts will be judged solely based on the data in the submitted abstract.

• All abstracts received will be evaluated by members of the Scientific Committee.
• Notification of acceptance or rejection of abstracts will be sent to the corresponding authors of each abstract by June 30th, 2025.
• Each abstract’s corresponding author will be notified of the evaluation procedure’s results. The corresponding author receives all information concerning the abstract and is responsible for informing all other co-authors of the status of the abstract.
• Presenting authors' registration deadline: July 20th, 2025. Please note that the online registration portal will be live on October 31st, 2024.
• All abstract presenters will be asked to reconfirm their attendance after receiving the notification. If you do not re-confirm your abstract presentation, register and pay the registration fee before the given deadline, your abstract(s) will be retracted from the Program.
• Accepted abstracts will be considered for Oral or Poster presentation. Please note that the Scientific Committee reserves the right to request the change of your abstract’s presentation type and/or session, according to the Program's specifications and needs.

Dear Colleagues and Friends,

We are thrilled to invite you to the 38th Congress of the International Union against Sexually Transmitted Infections (IUSTI)-Europe, to be held in Athens, Greece, between October 9-11, 2025. The theme of the Congress is “Sexual Health from Hippocrates to AI”.

This event will bring together leading experts and healthcare professionals from across Europe and beyond to discuss the latest developments in sexually transmitted infections, inflammatory skin diseases of the anogenital area and sexual health.

Athens, the capital of Greece, is the cradle of Western civilization. The city's landmark, Parthenon temple in Acropolis hill, is well-known around the world. A vibrant city with thousands of years of history and an abundance of archaeological, cultural and architectural treasures, Athens is blessed with an excellent Mediterranean climate and it is surrounded by the "big blue" of the Aegean Sea. This setting, along with a superb infrastructure in terms of accommodation, local transportation and recreation, make Athens an ideal venue for this important event.

The Organizing and Scientific Committees are committed to ensuring an unforgettable experience for every participant. We look forward to engaging discussions, meaningful exchanges of knowledge, and most importantly, your participation and valuable contributions to this outstanding event.

Come and join us to the journey from Hippocrates to AI!

We are looking forward to welcoming you to Athens!

Warm regards,

Electra Nicolaidou
Congress President
Professor of Dermatology and Venereology
1st Dept. Of Dermatology and Venereology, Medical School,
National and Kapodistrian University of Athens,
"Andreas Sygros" Hospital for Skin and Venereal Diseases, Athens, Greece

注册费：

• Admission to onsite scientific sessions and workshops
• Admission to exhibition
• Congress materials
• Certificate of Attendance
• Coffee – refreshments during official Congress breaks

◆ 参会对象：免疫学家，生物学家，医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。